Please enable Javascript
Jason Westin, MD
Articles by Jason Westin, MD
Jason Westin, MD, on the Phase III ZUMA-7 Primary OS Analysis
Jason Westin, MD
Aggressive B-Cell Lymphoma
|
September 5, 2023
The study compared axicabtagene ciloleucel with standard‑of‑care therapy in patients with relapsed or refractory LBCL.
View More